Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedA new Revision: v3.3.3 entry was added, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer/history.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedOnly a revision label update was made (v3.3.2 added, v3.3.1 removed) and no study information or page features were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.3.1 was added to the history, and the entry for v3.2.0 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the top banner notice regarding government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange DetectedThe two screenshots show minor visual and layout updates to the page header, navigation, and footer, with no changes to the record history content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.